1k1f: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="1k1f" size="450" color="white" frame="true" align="right" spinBox="true" caption="1k1f, resolution 2.20Å" /> '''Structure of the Bc...
 
OCA (talk | contribs)
No edit summary
 
(13 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Image:1k1f.gif|left|200px]]<br />
<applet load="1k1f" size="450" color="white" frame="true" align="right" spinBox="true"
caption="1k1f, resolution 2.20&Aring;" />
'''Structure of the Bcr-Abl Oncoprotein Oligomerization domain'''<br />


==Overview==
==Structure of the Bcr-Abl Oncoprotein Oligomerization domain==
The Bcr-Abl oncoprotein is responsible for a wide range of human, leukemias, including most cases of Philadelphia chromosome-positive, chronic myelogenous leukemia. Oligomerization of Bcr-Abl is essential for, oncogenicity. We determined the crystal structure of the N-terminal, oligomerization domain of Bcr-Abl (residues 1-72 or Bcr1-72) and found a, novel mode of oligomer formation. Two N-shaped monomers dimerize by, swapping N-terminal helices and by forming an antiparallel coiled coil, between C-terminal helices. Two dimers then stack onto each other to form, a tetramer. The Bcr1-72 structure provides a basis for the design of, inhibitors of Bcr-Abl transforming activity by disrupting Bcr-Abl, oligomerization.
<StructureSection load='1k1f' size='340' side='right'caption='[[1k1f]], [[Resolution|resolution]] 2.20&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[1k1f]] is a 8 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1K1F OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1K1F FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.2&#8491;</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=MSE:SELENOMETHIONINE'>MSE</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1k1f FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1k1f OCA], [https://pdbe.org/1k1f PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1k1f RCSB], [https://www.ebi.ac.uk/pdbsum/1k1f PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1k1f ProSAT]</span></td></tr>
</table>
== Disease ==
[https://www.uniprot.org/uniprot/BCR_HUMAN BCR_HUMAN] Note=A chromosomal aberration involving BCR is a cause of chronic myeloid leukemia. Translocation t(9;22)(q34;q11) with ABL1. The translocation produces a BCR-ABL found also in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
== Function ==
[https://www.uniprot.org/uniprot/BCR_HUMAN BCR_HUMAN] GTPase-activating protein for RAC1 and CDC42. Promotes the exchange of RAC or CDC42-bound GDP by GTP, thereby activating them. Displays serine/threonine kinase activity.<ref>PMID:1903516</ref> <ref>PMID:1657398</ref>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
The Bcr-Abl oncoprotein is responsible for a wide range of human leukemias, including most cases of Philadelphia chromosome-positive chronic myelogenous leukemia. Oligomerization of Bcr-Abl is essential for oncogenicity. We determined the crystal structure of the N-terminal oligomerization domain of Bcr-Abl (residues 1-72 or Bcr1-72) and found a novel mode of oligomer formation. Two N-shaped monomers dimerize by swapping N-terminal helices and by forming an antiparallel coiled coil between C-terminal helices. Two dimers then stack onto each other to form a tetramer. The Bcr1-72 structure provides a basis for the design of inhibitors of Bcr-Abl transforming activity by disrupting Bcr-Abl oligomerization.


==Disease==
Structure of the Bcr-Abl oncoprotein oligomerization domain.,Zhao X, Ghaffari S, Lodish H, Malashkevich VN, Kim PS Nat Struct Biol. 2002 Feb;9(2):117-20. PMID:11780146<ref>PMID:11780146</ref>
Known diseases associated with this structure: Leukemia, acute lymphocytic OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=151410 151410]], Leukemia, chronic myeloid OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=151410 151410]]


==About this Structure==
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
1K1F is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1K1F OCA].
</div>
 
<div class="pdbe-citations 1k1f" style="background-color:#fffaf0;"></div>
==Reference==
== References ==
Structure of the Bcr-Abl oncoprotein oligomerization domain., Zhao X, Ghaffari S, Lodish H, Malashkevich VN, Kim PS, Nat Struct Biol. 2002 Feb;9(2):117-20. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=11780146 11780146]
<references/>
__TOC__
</StructureSection>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Large Structures]]
[[Category: Ghaffari, S.]]
[[Category: Ghaffari S]]
[[Category: Kim, P.S.]]
[[Category: Kim PS]]
[[Category: Lodish, H.]]
[[Category: Lodish H]]
[[Category: Malashkevich, V.N.]]
[[Category: Malashkevich VN]]
[[Category: Zhao, X.]]
[[Category: Zhao X]]
[[Category: bcr-abl kinase]]
[[Category: coiled coil]]
[[Category: oligomerization]]
 
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 17:46:31 2007''

Latest revision as of 11:23, 2 August 2023

Structure of the Bcr-Abl Oncoprotein Oligomerization domain

1k1f, resolution 2.20Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA